Canada’s regulatory approach to drugs for rare diseases: orphan drugs

Name: Canada’s regulatory approach to drugs for rare diseases: orphan drugs
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

Canada's regulatory approach: Drugs for rare diseases are authorized for sale in Canada under the Food and Drugs Act and Part C of the Food and Drug Regulations.